16-3608868-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_032444.4(SLX4):c.97G>A(p.Asp33Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D33E) has been classified as Uncertain significance.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group PInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLX4 | NM_032444.4 | c.97G>A | p.Asp33Asn | missense_variant | Exon 2 of 15 | ENST00000294008.4 | NP_115820.2 | |
| SLX4 | XM_024450471.2 | c.97G>A | p.Asp33Asn | missense_variant | Exon 2 of 15 | XP_024306239.1 | ||
| SLX4 | XM_011522715.4 | c.97G>A | p.Asp33Asn | missense_variant | Exon 2 of 15 | XP_011521017.1 | ||
| SLX4 | XR_007064923.1 | n.746G>A | non_coding_transcript_exon_variant | Exon 2 of 13 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLX4 | ENST00000294008.4 | c.97G>A | p.Asp33Asn | missense_variant | Exon 2 of 15 | 5 | NM_032444.4 | ENSP00000294008.3 | ||
| SLX4 | ENST00000466154.5 | n.392G>A | non_coding_transcript_exon_variant | Exon 1 of 7 | 1 | |||||
| SLX4 | ENST00000486524.1 | n.725G>A | non_coding_transcript_exon_variant | Exon 2 of 4 | 2 | |||||
| SLX4 | ENST00000697859.1 | n.719G>A | non_coding_transcript_exon_variant | Exon 2 of 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251474 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.97G>A (p.D33N) alteration is located in exon 2 (coding exon 1) of the SLX4 gene. This alteration results from a G to A substitution at nucleotide position 97, causing the aspartic acid (D) at amino acid position 33 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at